NM_000751.3:c.946G>A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting
The NM_000751.3(CHRND):c.946G>A(p.Gly316Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000762 in 1,614,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000751.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRND | NM_000751.3 | c.946G>A | p.Gly316Ser | missense_variant | Exon 9 of 12 | ENST00000258385.8 | NP_000742.1 | |
CHRND | NM_001256657.2 | c.901G>A | p.Gly301Ser | missense_variant | Exon 8 of 11 | NP_001243586.1 | ||
CHRND | NM_001311196.2 | c.643G>A | p.Gly215Ser | missense_variant | Exon 9 of 12 | NP_001298125.1 | ||
CHRND | NM_001311195.2 | c.364G>A | p.Gly122Ser | missense_variant | Exon 7 of 10 | NP_001298124.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152158Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000115 AC: 29AN: 251452Hom.: 0 AF XY: 0.000132 AC XY: 18AN XY: 135904
GnomAD4 exome AF: 0.0000527 AC: 77AN: 1461794Hom.: 0 Cov.: 33 AF XY: 0.0000509 AC XY: 37AN XY: 727206
GnomAD4 genome AF: 0.000302 AC: 46AN: 152276Hom.: 0 Cov.: 31 AF XY: 0.000296 AC XY: 22AN XY: 74450
ClinVar
Submissions by phenotype
not specified Uncertain:2
The G316S variant in the CHRND gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The G316S variant was not observed at any significant frequency in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The G316S variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret G316S as a variant of uncertain significance. -
- -
Inborn genetic diseases Uncertain:1
The c.946G>A (p.G316S) alteration is located in exon 9 (coding exon 9) of the CHRND gene. This alteration results from a G to A substitution at nucleotide position 946, causing the glycine (G) at amino acid position 316 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
- -
Lethal multiple pterygium syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at